Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes

Biology of Blood and Marrow Transplantation - Tập 23 - Trang 2166-2171 - 2017
Gabriela Rondón1, Rima M. Saliba1, Julianne Chen1, Celina Ledesma1, Amin M. Alousi1, Betul Oran1, Chitra M. Hosing1, Partow Kebriaei1, Issa F. Khouri1, Elizabeth J. Shpall1, Uday R. Popat1, Richard E. Champlin1, Stefan O. Ciurea1
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Tài liệu tham khảo

Trotti, 2007, Patient-reported outcomes and the evolution of adverse event reporting in oncology, J Clin Oncol, 25, 5121, 10.1200/JCO.2007.12.4784 US Department of Health and Human Services: National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0; 2009. National Cancer Institute Wieduwilt Gooley, 2010, Reduced mortality after allogeneic hematopoietic cell transplantation, N Engl J Med, 363, 2091, 10.1056/NEJMoa1004383 Horan, 2011, Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?, J Clin Oncol, 29, 805, 10.1200/JCO.2010.32.5001 Bearman, 1988, Regimen-related toxicity in patients undergoing bone marrow transplantation, J Clin Oncol, 6, 1562, 10.1200/JCO.1988.6.10.1562 Chou, 2012, Serial assessment of toxicity after hematopoietic SCT can discern kinetics of transplant-related organ injury and patterns of recovery, Bone Marrow Transplant, 47, 1375, 10.1038/bmt.2012.27 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Cox, 1972, Regression models and life-tables, J R Stat Soc B, 34, 187 Gaballa, 2016, Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation, Cancer, 122, 3316, 10.1002/cncr.30180 Alatrash, 2011, Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life, Biol Blood Marrow Transplant, 17, 1490, 10.1016/j.bbmt.2011.02.007 O'Connor, 2015, Fluid overload, Crit Care Clin, 31, 803, 10.1016/j.ccc.2015.06.013 Rimkus, 2009, Acute complications of stem cell transplant, Semin Oncol Nurs, 25, 129, 10.1016/j.soncn.2009.03.007